• About
  • Products
  • News
  • Investor
    • Corporate
    • Financial
    • Stock
  • Contact Us

PanGenomic Health Expands NaraCare.AI Platform with Launch of DNA Testing Program

by PanGenomic | October 20, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health’s Subsidiary Mindleap Health Selects Hong Kong for its Health AI Centre Operations

by PanGenomic | September 23, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health to Launch Real-World Evidence Platform for Complementary & Alternative Medicine through Mindleap Health Subsidiary

by PanGenomic | September 9, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health to Showcase Agenta Health at Vivacity Conference and Completes Warrant Financing

by PanGenomic | August 26, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health Launches AGENTA Health eCommerce Platform and Provides Warrant Financing Update

by PanGenomic | August 20, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health Provides Corporate Update

by PanGenomic | July 25, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health Announces Financial Results for the 2024 Fiscal Year

by PanGenomic | July 25, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health Announces Changes to Board of Directors and Management,Warrant Update and Stock Option Grants

by PanGenomic | July 11, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health Retains Investor Relations Firm and Provides Update on Warrant Expiration Date

by PanGenomic | June 23, 2025 | Business Update | 0 Comments

Read More

PanGenomic Health Provides Update on Management Cease Trade Order

by PanGenomic | June 17, 2025 | Business Update | 0 Comments

Read More
Business Update

PanGenomic Health Expands NaraCare.AI Platform with Launch of DNA Testing Program

PanGenomic
Oct 20, 2025
Business Update

PanGenomic Health’s Subsidiary Mindleap Health Selects Hong Kong for its Health AI Centre Operations

PanGenomic
Sep 23, 2025
Business Update

PanGenomic Health to Launch Real-World Evidence Platform for Complementary & Alternative Medicine through Mindleap Health Subsidiary

PanGenomic
Sep 09, 2025
Business Update

PanGenomic Health to Showcase Agenta Health at Vivacity Conference and Completes Warrant Financing

PanGenomic
Aug 26, 2025
Business Update

PanGenomic Health Launches AGENTA Health eCommerce Platform and Provides Warrant Financing Update

PanGenomic
Aug 20, 2025
Business Update

PanGenomic Health Provides Corporate Update

PanGenomic
Jul 25, 2025
Business Update

PanGenomic Health Announces Financial Results for the 2024 Fiscal Year

PanGenomic
Jul 25, 2025
Business Update

PanGenomic Health Announces Changes to Board of Directors and Management,Warrant Update and Stock Option Grants

PanGenomic
Jul 11, 2025
Business Update

PanGenomic Health Retains Investor Relations Firm and Provides Update on Warrant Expiration Date

PanGenomic
Jun 23, 2025
Business Update

PanGenomic Health Provides Update on Management Cease Trade Order

PanGenomic
Jun 17, 2025
Business Update

PanGenomic Health Provides Update on Management Cease Trade Order

PanGenomic
May 29, 2025
Business Update, Uncategorized

PanGenomic Health Provides Update on Management Cease Trade Order

PanGenomic
May 15, 2025
Uncategorized

PanGenomic Health Announces Issuance of Management Cease Trade Order for Late Filing of Audited Annual Financial Statements

PanGenomic
May 01, 2025
Business Update

PanGenomic Health Announces Management Change

PanGenomic
Apr 03, 2025
Business Update

PanGenomic Health Announces Repricing of Outstanding Warrants

PanGenomic
Jan 29, 2025
Business Update

PanGenomic Health Closes Private Placement Offering for Cash Proceeds and to Settle Indebtedness totalling $750,000

PanGenomic
Jan 10, 2025
Business Update

PanGenomic Health Announces Intention to Reprice Outstanding Warrants

PanGenomic
Jan 09, 2025
Business Update

PanGenomic Health Announces Private Placement Offering for Gross Proceeds and to Settle Indebtedness of up to $750,000

PanGenomic
Dec 31, 2024
Business Update

PanGenomic Health Announces Completion of Consolidation

PanGenomic
Nov 14, 2024
Business Update

PanGenomic Health Announces Proposed Consolidation

PanGenomic
Nov 07, 2024
Business Update

PanGenomic Health Announces AGM Result

PanGenomic
Oct 31, 2024
Business Update

PanGenomic Health Announces Financial Results for the 2023 Fiscal Year and Q1 2024

PanGenomic
Jul 30, 2024
Business Update

PanGenomic Health Provides Update on Management Cease Trade Order

PanGenomic
Jun 25, 2024
Business Update

PanGenomic Health Provides Update on Management Cease Trade Order

PanGenomic
Jun 11, 2024
Business Update

PanGenomic Health Provides Update on Management Cease Trade Order

PanGenomic
May 28, 2024
Business Update

PanGenomic Health Closes Private Placement to Settle Outstanding Debts in the Amount of $1,075,000

PanGenomic
May 27, 2024
Business Update

PanGenomic Health Announces Plans to Settle Outstanding Debts of $1 Million in Private Placement Offering

PanGenomic
May 17, 2024
Business Update

PanGenomic Health Announces Issuance of Management Cease Trade Order For Late Filing of Audited Annual Financial Statements

PanGenomic
May 17, 2024
Uncategorized

PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements

PanGenomic
Apr 12, 2024
Uncategorized

PanGenomic Health Announces Completion of Consolidation

PanGenomic
Mar 21, 2024
Uncategorized

PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE

PanGenomic
Mar 18, 2024
Business Update

PanGenomic Health Announces Withdrawal from AQSE

PanGenomic
Feb 20, 2024
Business Update

PanGenomic Health Announces Changes to Board of Directors

PanGenomic
Feb 16, 2024
Business Update

PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility

PanGenomic
Jan 09, 2024
Business Update

PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report

PanGenomic
Mar 09, 2023
Business Update

PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs

PanGenomic
Jan 23, 2023
  • Follow
  • Follow
  • Follow
  • Follow

GET IN TOUCH

info@pangenomic.com

Privacy Policy

© 2025 PanGenomic Health Inc.
A public benefit company.

Manage Cookie Consent
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}